ZNF750 loss defines an ESCC subtype with constitutive NF-κB activation and vulnerability to bortezomib
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-08 · 1872 (6) · 168282
DOI: 10.1016/j.bbadis.2026.168282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-08. Verfasst von Yanghui Bi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center of Gene Sequencing, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical Univ…. Hauptthemen laut MEDLINE: Bortezomib, Esophageal Squamous Cell Carcinoma, NF-kappa B, Esophageal Neoplasms. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic Research Programs of Sichuan Province, Science and Technology Innovation Team of Shanxi Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Gene Sequencing, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China; Department of Pathology & Shanxi Key L…
- Shanxi Academy of Medical Sciences, Shanxi Medical University, Taiyuan, 030001, China.
- Endoscopic Center of Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China.
- Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
- Department of Pathology, the First Hospital, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
- Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Science, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China.
Förderung
- National Natural Science Foundation of China
- Basic Research Programs of Sichuan Province
- Science and Technology Innovation Team of Shanxi Province
- National Key Research and Development Program of China
Zitieren
APA
Bi, Y., Wang, M., Zhang, Y., Cui, H., Cheng, C., Song, B., Zhang, L., Kong, P., Yang, B., Yuan, F., Zhang, R., & Cui, Y. (2026). ZNF750 loss defines an ESCC subtype with constitutive NF-κB activation and vulnerability to bortezomib. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(6), 168282. https://doi.org/10.1016/j.bbadis.2026.168282
Vancouver
Bi Y, Wang M, Zhang Y, Cui H, Cheng C, Song B, et al. ZNF750 loss defines an ESCC subtype with constitutive NF-κB activation and vulnerability to bortezomib. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(6):168282. doi:10.1016/j.bbadis.2026.168282
BibTeX
@article{Bi2026,
author = {Bi, Yanghui and Wang, Mengyao and Zhang, Yong and Cui, Heyang and Cheng, Caixia and Song, Bin and Zhang, Ling and Kong, Pengzhou and Yang, Bin and Yuan, Fajia and Zhang, Ruiping and Cui, Yongping},
title = {ZNF750 loss defines an ESCC subtype with constitutive NF-κB activation and vulnerability to bortezomib},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2026},
volume = {1872},
number = {6},
pages = {168282},
doi = {10.1016/j.bbadis.2026.168282}
}
EUVIMED